High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history

Cancer Research

Volumn 59, Issue 5, 1999, Pages 995-998

  Csokay, Bela ^a   Udvarhelyi, Nora ^a   Sulyok, Zoltan ^a   Besznyak, Istvan ^a   Ramus, Susan ^b   Ponder, Bruce ^b   Olah, Edith ^a  

^a NATIONAL INSTITUTE OF ONCOLOGY   (Hungary)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BREAST CANCER; CANCER RISK; CANCER SCREENING; FAMILY HISTORY; GENE FREQUENCY; GENE MUTATION; GENETIC PREDISPOSITION; GERM LINE; GYNECOMASTIA; HUMAN; HUMAN CELL; HUNGARY; MALE BREAST; MULTIGENE FAMILY; PRIORITY JOURNAL;

ADENOCARCINOMA; BRCA2 PROTEIN; BREAST NEOPLASMS, MALE; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CODON; CODON, TERMINATOR; DNA; DNA TRANSPOSABLE ELEMENTS; EXONS; FAMILY; FEMALE; FRAMESHIFT MUTATION; GENES, BRCA1; GENETIC MARKERS; GERM-LINE MUTATION; GYNECOMASTIA; HUMANS; HUNGARY; LYMPHOCYTES; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; SEQUENCE DELETION; TRANSCRIPTION FACTORS;

EID: 0033104409     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. La Vecchia, C., Levi, F., and Lucchini, F. Descriptive epidemiology of male breast cancer in Europe. Int. J. Cancer. 51: 62-66, 1992.
2. Szabo, C. I., and King, M-C. Inherited breast and ovarian cancer. Hum. Mol. Genet., 4: 1811-1817, 1995.
3. Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., Bishop, D. T., Weber, B., Lenoir, G., Chang-Claude, J., Sobol, H., Teare, M. D., Stuewing, J., Arason, A., Scherneck, S., Peto, J., Rebbeck, T. R., Tonin, P., Neuhausen, S., Barkardottir, R., Eyfjord, J., Lynch, H., Ponder, B. A. J., Gayther, S. A., Birch, J. M., Lindblom, A., Stoppa-Lyonnet, D., Bignon, Y., Borg, A., Hamann, U., Haites, N., Scott, R. J., Maugard, C. M., Vasen, H., Seitz, S., Cannon-Albright, L. A., Schofield, A., Zelada-Hedman, M., and the Breast Cancer Linkage Consortium. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. Am. J. Hum. Genet., 62: 676-689, 1998.
4. Wooster, R., Bignell, G., Lancaster, J., Swift, S., Seal, S., Mangion, J., Collins, N., Gregory, S., Gumbs, C., Micklem, G., Barfoot, R., Hamoudi, R., Patel, S., Rice, C., Biggs, P., Hashim, Y., Smith, A., Connor, F., Arason, A., Gudmundsson, J., Ficenec, D., Kelsell, D., Ford, D., Tonin, P., Bishop, D. T., Spurr, N. K., Ponder, B. A. J., Eeles, R., Peto, J., Devilee, P., Cornelisse, C., Lynch, H., Narod, S.. Lenoir. G.. Egilsson, V., Barkardottir, R. B., Easton, D. F., Bentley, D. R., Futreal, P. A., Ashworth, A., and Stratton, M. R. Identification of the breast cancer susceptibility-gene BRCA2. Nature (Lond.), 378: 789-792, 1995.
5. Ramus, S. J., Kote-Jarai, Z., van der Looij, M., Gayther, S. A., Csokay, B., Ponder, B. A. J., and Olah, E. Analysis of BRCA1 and BRCA2 mutations in Hungarian families with breast and breast-ovarian cancer. Am. J. Hum. Genet., 60: 1242-1246, 1997.
6. Anelli, A., Anelli, T. M. F., Youngson, B., Rosen, P. P., and Borgen, P. I. Mutations of the p53 gene in male breast cancer. Cancer (Phila.), 75: 2233-2238, 1995.
7. Lobaccaro, J. M., Lumbroso, S., Belon, C., Galtier-Dereure, F., Bringer, J., Lesimple, T., Namer, M., Cutuli, B. F., Pujol, H., and Sultan, C. Androgen receptor gene mutation in male breast cancer. Hum. Mol. Genet., 2: 1799-1802, 1993.
8. Struewing, J. P., Brody, L. C., Erdos, M. R., Kase, R. G., Giambarresi, T. R., Smith, S. A., Collins, F. S., and Tucker, M. A. Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including 1 family with male breast cancer. Am. J. Hum. Genet., 57: 1-7, 1995.
9. Hogervorst, F. B. L., Cornelis, R. S., Bout, M., van Vliet, M., Oosterwijk, J. C., Olmer, R., Bakker, B., Klijn, J. G. M., Vasen, H. F. A., Meijers-Heijboer, H., Menko, F. H., Cornelisse, C. J., den Dunnen, J. T., Devilee, P., and van Ommen, G-J. B. Rapid detection of BRCA1 mutations by the protein truncation test. Nat. Genet., 10: 208-212, 1995.
10. Serova, O. M., Montagna, M., Torchard, D., Narod, S., Tonin, P., Sylla, B., Lynch, H. T., Feunteun, J., and Lenoir, G. M. A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am. J. Hum. Genet., 58: 42-51, 1996.
11. Couch, F. J. Farid, L. M., DeShano, M. L., Tavtigian, S. V., Calzone, K., Campeau, L., Peng, Y., Bogden, B., Chen, Q., Neuhausen, S., Shattuck-Eidens, D., Godwin, A. K., Daly, M., Radford, D. M., Sedlacek, S., Rommens, J., Simard, J., Garber, J., Merajver, S., and Weber, B. L. BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat. Genet., 13: 123-125, 1996.
12. Phelan, C. M., Lancaster, J. M., Tonin, P., Gumbs, C., Cochran, C., Carter, R., Ghadirian, P., Perret, C. Moslehi, R., Dion, F., Faucher, M-C., Dole, K., Karimi, S., Foulkes, W., Lounis, H., Warner, E., Goss, P., Anderson, D., Larsson, C., Narod, S. A., and Futreal, P. A. Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families. Nat. Genet., 13: 120-122, 1996.
13. Thorlacius, S., Olafsdottir, G., Tryggvadottir, L., Neuhausen, S., Jonasson, J. G., Tavtigian, S. V., Tulinius, H., Ogmundsdottir, H. M., and Eyfjord, J. E. A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes. Nat. Genet., 13: 117-119, 1996.
14. Hoskins, K. F., Stopfer, J. E., Calzone, K. A., Merajver, S. D., Rebbeck, T. R., Garber, J. E., and Weber, B. L. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. J. Am. Med Assoc., 273: 577-585, 1995.
15. Meyskens, F. L., Jr., Tormey, D. C., and Neifeld, J. P. Male breast cancer: a review. Cancer Treat. Rev., 3: 83-93, 1976.
16. Cutuli, B., Dilhuydy, J. M., De Lafontan, B., Berlie, J., Lacroze, M., Lesaunier, F., Graic, Y., Tortochaux, J., Resbeut, M., Lesimple, T., Gamelin, E., Campana, F., Reme-Saumon, M., Moncho-Bernier, V., Cuilliere, J. C., Marchal, C., De Gislain, G., N'Guyen, T. D., Teissier, E., and Velten, M. Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur. J. Cancer. 33: 35-38, 1997.
17. Ramus, S. J., Friedman, L. S., Gayther, S. A., Ponder, B. A. J., Bobrow, L., van der Looij, M., Papp, J., and Olah, E. A breast/ovarian cancer patient with germline mutations in both the BRCA1 and BRCA2 genes. Nat. Genet., 15: 14-15, 1997.
18. Tavtigian, S. V., Simard, J., Rommens, J., Couch, F., Shattuck-Eidens, D., Neuhausen, S., Merajver, S., Thorlacius, S., Offit, K., Stoppa-Lyonnet, D., Belanger, C., Bell, R., Berry, S., Bogden, R., Chen, Q., Davis, T., Dumont, M., Frye, C., Hattier, T., Jammulapati, S., Janecki, T., Jiang, P., Kehrer, R., Leblanc, J-F., Mitchell, J. T., McArthur-Morrison, J., Nguyen, K., Peng, Y., Samson, C., Schroeder, M., Snyder, S. C., Steele, L., Stringfellow, M., Stroup, C., Swedlund, B., Swensen, J., Teng, D., Thomas, A., Tran, T., Tran, T., Tranchant, M., Weaver-Feldhaus, J., Wong, A. K. C., Shizuya, H., Eyfjord, J. E., Cannon-Albright, L., Labrie, F., Skolnick, M. H., Weber, B., Kamb, A., and Goldgar, D. E. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat. Genet., 12: 333-337, 1996.
19. Serova, O. M., Boutrand, L., Stoppa-Lyonnet, D., Bressac-de-Paillerets, B., Dubois, V., Lasset, C. Janin, N., Bignon, Y., Longy, M., Maugard, C., Lidereau, R., Leroux, D., Frebourg, T., Mazoyer, S., and Lenoir, G. M. BRCA2 mutations in hereditary breast and ovarian cancer in France. Am. J. Hum. Genet., 60: 1236-1239, 1997.
20. Mavraki, E., Gray, I. C., Bishop, D. T., and Spurr, N. K. Germline BRCA2 mutations in men with breast cancel. Br. J. Cancer, 76: 1428-1431, 1997.
21. Friedman, L. S., Gayther, S. A., Kurosaki, T., Gordon, D., Noble, B., Casey, G., Ponder, B. A. J., and Anton-Culver, H. Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am. J. Hum. Genet., 60: 313-319, 1997.
22. Haraldsson, K., Loman, N., Zhang, Q-X., Johannsson, O., Olsson, H., and Borg, A. BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res., 58: 1367-1371, 1998.
23. Thorlacius, S., Sigurdsson, S., Bjarnadottir, H., Olafsdottir, G., Jonasson, J. G., Tryggvadottir, L., Tulinius, H., and Eyfjord, J. E. Study of a single BRCA2 mutation with high carrier frequency in a small population. Am. J. Hum. Genet., 60: 1079-1084, 1997.
24. Rosenblatt, K. A., Thomas, D. B., McTiernan, A., Austin, M. A., Stalsberg, H., Stemhagen, A., Thompson, W. D. Curnen, M. G., Satariano, W., and Austin, D. F. Breast cancer in men: aspects of familial aggregation. J. Natl. Cancer Inst., 83: 849-854, 1991.
25. Donegan, W. L., and Redlich, P. N. Breast cancer in men. Surg. Clin. N. Am., 76: 343-363, 1996.
26. Neuhausen, S. L., Godwin, A. K., Gershoni-Baruch, R., Schubert, E., Garber, J., Stoppa-Lyonnet, D., Olah, E., Csokay, B., Serova, O., Lalloo, F., Osorio, A., Stratton, M., Offit, K., Boyd, J., Caligo, M. A., Scott, R. J., Schofield, A., Teugels, E., Schwab, M., Cannon-Albright, L., Bishop, T., Easton, D., Benitez, J., King, M-C., Ponder, B. A. J., Weber, B., Devilee, P., Borg, A., Narod, S. A., and Goldgar, D. Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am. J. Hum. Genet., 62: 1381-1388, 1998.
27. Savelyeva, L., Claas, A., Gier, S., Schlag, P., Finke, L., Mangion, J., Stratton, M. R., and Schwab, M. An interstitial tandem duplication of 9p23-24 coexist with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer. Cancer Res., 58: 863-866, 1998.